Answers are grounded in this paper and cite their sources.
Objective: We aimed to compare the impacts of retrograde ureteral stent (RUS) and percutaneous nephrostomy (PCN) which were placed for hydronephrosis secondary to onco-gynecology surgeries on health-related quality of life. Materials and methods:The datas of 42 patients who required placement of RUS or PCN for hydronephrosis secondary to onco-gynecology surgeries and followed up between January 2013 and December 2017 were retrospectively evaluated.Patients were divided into two groups: RUS (n:19) and PCN (n:23).We compared the health-related quality of life and catheter related undesirable symptoms between two groups.Results: In the evaluation of patients' physical and psychosocial well-being, problems related to mobility (p=0.002),self care (p=0.01),daily physical activity (p=0.01) and severity of anxiety/depression (p<0.001) were found higher in PCN group.On the other hand, pain (p=0.001) and daily need of analgesia (p=0.016) were higher in patients with RUS.Dysuria (p=0.038),urgency (p=0.038) and frequency (p=0.006) were catheter related undesired symptoms and they were significantly higher in RUS group.We used VAS score as an indicator of general well-being.VAS scores were 5.42 ± 1.53 and 4.70 ± 1.29 in RUS and PCN groups, respectively (p = 0.105).Conclusion: RUS and PCN have equally success for urgent decompression of upper urinary tract.In the patients with hydronephrosis secondary to ureteral obstruction following onco-gynecology surgeries, we observed that none of two urinary drainage methods was better tolerated in terms of general well-being.However, physical and psychosocial well-being was worse in PCN group.
No takes yet. Share an insight, caveat, or question.
İsmail Selvi (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: